Loading organizations...
§ Private Profile · 225 N. Michigan Suite 1430 Chicago, IL 60601, USA
NOCD is a technology company.
NOCD has raised $84.0M across 5 funding rounds.
Key people at NOCD.
NOCD has raised $84.0M in total across 5 funding rounds.
NOCD operates a specialized telehealth platform focused on delivering evidence-based treatment for Obsessive-Compulsive Disorder (OCD). The company's core product provides virtual Exposure and Response Prevention (ERP) therapy, integrating a mobile application for symptom tracking and progress monitoring, alongside a supportive community forum. This comprehensive approach aims to make highly effective, yet often difficult-to-access, therapy readily available to individuals.
The company's inception stemmed from the personal experience of co-founder and CEO Stephen Smith, who began sketching the foundational idea in 2014, leading to NOCD's launch in 2015. After grappling with his own misdiagnosed and mistreated OCD, Stephen recognized a critical void in the healthcare system for affordable and accessible specialized care. He later brought on Anil Vaitla as Chief Technology Officer, Ilyas Patanam as Chief Growth Officer, and Larry Trusky as President to build out the platform.
NOCD serves individuals living with OCD, providing them with a structured pathway to recovery through professional guidance and peer support. Its overarching mission is to restore hope for this community by enhancing awareness and transforming access to effective treatment. The company envisions a future where anyone in need can access affordable, high-quality ERP therapy, bridging significant gaps in mental healthcare delivery.
Key people at NOCD.
NOCD is a Chicago-based digital health company providing specialized telehealth treatment for obsessive-compulsive disorder (OCD), primarily through Exposure and Response Prevention (ERP) therapy—the gold standard for OCD.[1][2][3][5] It connects users with licensed OCD-specialist therapists via live video sessions, supplemented by 24/7 in-app tools, self-help resources, and a peer community of nearly one million members, serving individuals across diverse backgrounds while accepting most insurance plans for about half of Americans.[1][3][5] NOCD addresses the severe shortage of OCD specialists by delivering virtual ERP twice as fast as traditional methods, with peer-reviewed studies showing effectiveness for around 90% of members and partnerships with major insurers driving growth.[3][5]
NOCD was founded around 2014-2015 by Stephen Smith (CEO), who has OCD himself, alongside a team many of whom share lived experience with the condition, driven by a mission to restore hope through better awareness and accessible treatment.[1][3][4] The idea emerged from personal challenges and the lack of effective OCD care, evolving into the world's largest OCD community and leading telehealth provider over the past decade, marked by pivotal scaling through insurance partnerships and clinician-led innovations.[3] Key leaders like Jamie Feusner (Chief Medical Officer), a scaling expert, emphasize the mission-driven team's accountability to members, enabling rapid growth while prioritizing treatment experience.[3]
NOCD rides the telehealth and digital mental health boom, capitalizing on post-pandemic demand for accessible behavioral care amid therapist shortages, especially for underserved OCD (one of the most severe yet misunderstood conditions).[1][4][5] Timing aligns with insurer adoption of virtual platforms and AI-enhanced tools in competitors like NeuroFlow or Youper, but NOCD's specialist focus differentiates it in a commoditizing market.[1] It influences the ecosystem by proving scalable ERP, building massive communities, and validating outcomes through research, pushing payers toward evidence-based digital therapies.[3][5]
NOCD is poised for expansion through deeper insurance integrations, app enhancements, and potential AI for personalization, amid rising mental health investment despite telehealth scrutiny.[1][3] Trends like integrated behavioral-physical health and wearables (e.g., competitors' approaches) will shape it, potentially evolving NOCD into a broader platform while maintaining OCD leadership.[1] Its community-driven model positions it to sustain influence, turning specialized telehealth into a hope-restoring force as in its founding mission.[3]
NOCD has raised $84.0M across 5 funding rounds. Most recently, it raised $34.0M Series B in January 2023.
NOCD has raised $84.0M in total across 5 funding rounds.
NOCD's investors include 7wire Ventures, Craig Cimini, Advent Life Sciences, Draper Associates, F-Prime Capital Partners, General Catalyst, Global Ventures, Latitud, Maverick Capital, Picus Capital, Questa Capital, Curtis Chambers.
